330 related articles for article (PubMed ID: 32657748)
1. The Neurofibromatoses.
Farschtschi S; Mautner VF; McLean ACL; Schulz A; Friedrich RE; Rosahl SK
Dtsch Arztebl Int; 2020 May; 117(20):354-360. PubMed ID: 32657748
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
[TBL] [Abstract][Full Text] [Related]
3. [Neurofibromatosis].
Wolkenstein P; Decq P
Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
[TBL] [Abstract][Full Text] [Related]
4. Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis.
Brown R
Curr Oncol Rep; 2023 Dec; 25(12):1409-1417. PubMed ID: 37906356
[TBL] [Abstract][Full Text] [Related]
5. Available Therapies for Patients with Neurofibromatosis-Related Nervous System Tumors.
Strowd RE
Curr Treat Options Oncol; 2020 Aug; 21(10):81. PubMed ID: 32767156
[TBL] [Abstract][Full Text] [Related]
6. The neurofibromatoses. An overview.
Ruggieri M; Huson SM
Ital J Neurol Sci; 1999 Apr; 20(2):89-108. PubMed ID: 10933430
[TBL] [Abstract][Full Text] [Related]
7. [Neurofibromatosis versus schwannomatosis].
Mautner VF; Schröder S; Pulst SM; Ostertag H; Kluwe L
Fortschr Neurol Psychiatr; 1998 Jun; 66(6):271-7. PubMed ID: 9676422
[TBL] [Abstract][Full Text] [Related]
8. [Eye involvement in neurofibromatosis].
Baier M; Pitz S
Ophthalmologe; 2016 May; 113(5):443-52. PubMed ID: 27142037
[TBL] [Abstract][Full Text] [Related]
9. The different forms of neurofibromatosis.
Ruggieri M
Childs Nerv Syst; 1999 Jul; 15(6-7):295-308. PubMed ID: 10461778
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis.
Korf BR
Handb Clin Neurol; 2013; 111():333-40. PubMed ID: 23622184
[TBL] [Abstract][Full Text] [Related]
11. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.
Widemann BC; Acosta MT; Ammoun S; Belzberg AJ; Bernards A; Blakeley J; Bretscher A; Cichowski K; Clapp DW; Dombi E; Evans GD; Ferner R; Fernandez-Valle C; Fisher MJ; Giovannini M; Gutmann DH; Hanemann CO; Hennigan R; Huson S; Ingram D; Kissil J; Korf BR; Legius E; Packer RJ; McClatchey AI; McCormick F; North K; Pehrsson M; Plotkin SR; Ramesh V; Ratner N; Schirmer S; Sherman L; Schorry E; Stevenson D; Stewart DR; Ullrich N; Bakker AC; Morrison H
Am J Med Genet A; 2014 Mar; 164A(3):563-78. PubMed ID: 24443315
[TBL] [Abstract][Full Text] [Related]
12. Schwannomatosis: the overlooked neurofibromatosis?
Koontz NA; Wiens AL; Agarwal A; Hingtgen CM; Emerson RE; Mosier KM
AJR Am J Roentgenol; 2013 Jun; 200(6):W646-53. PubMed ID: 23701098
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis.
Plotkin SR; Bredella MA; Cai W; Kassarjian A; Harris GJ; Esparza S; Merker VL; Munn LL; Muzikansky A; Askenazi M; Nguyen R; Wenzel R; Mautner VF
PLoS One; 2012; 7(4):e35711. PubMed ID: 22558206
[TBL] [Abstract][Full Text] [Related]
14. The neurofibromatoses.
Ferner RE
Pract Neurol; 2010 Apr; 10(2):82-93. PubMed ID: 20308235
[TBL] [Abstract][Full Text] [Related]
15. The Neurofibromatoses. Part 1: NF1.
Lu-Emerson C; Plotkin SR
Rev Neurol Dis; 2009; 6(2):E47-53. PubMed ID: 19587630
[TBL] [Abstract][Full Text] [Related]
16. From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis.
Ferner RE; Bakker A; Elgersma Y; Evans DGR; Giovannini M; Legius E; Lloyd A; Messiaen LM; Plotkin S; Reilly KM; Schindeler A; Smith MJ; Ullrich NJ; Widemann B; Sherman LS
Am J Med Genet A; 2019 Jun; 179(6):1098-1106. PubMed ID: 30908866
[TBL] [Abstract][Full Text] [Related]
17. Management of multiple tumors in neurofibromatosis type 2 patients.
Aboukais R; Bonne NX; Baroncini M; Zairi F; Schapira S; Vincent C; Lejeune JP
Neurochirurgie; 2018 Nov; 64(5):364-369. PubMed ID: 26071178
[TBL] [Abstract][Full Text] [Related]
18. Plasma S100β is not a useful biomarker for tumor burden in neurofibromatosis.
Smith MJ; Esparza S; Merker VL; Muzikansky A; Bredella MA; Harris GJ; Kassarjian A; Cai W; Walker JA; Mautner VF; Plotkin SR
Clin Biochem; 2013 May; 46(7-8):698-700. PubMed ID: 23261835
[TBL] [Abstract][Full Text] [Related]
19. New classification and approaches to the treatment of schwannomatosis.
Makashova ES; Zolotova SV; Absalyamova OV; Galkin MV; Petrokovskaya AV; Kozlov AV; Golanov AV
Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(5):104-109. PubMed ID: 37830475
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas.
Kehrer-Sawatzki H; Kluwe L; Friedrich RE; Summerer A; Schäfer E; Wahlländer U; Matthies C; Gugel I; Farschtschi S; Hagel C; Cooper DN; Mautner VF
Hum Genet; 2018 Jul; 137(6-7):543-552. PubMed ID: 30006736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
